AEON · AEON Biopharma, Inc. · Executive Compensation
$0.23
+0.00 (+0.17%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result of these conditions, management has concluded that substantial doubt about our ability to continue as a going concern exists as conditions and events, considered in the aggregate, indicate that it is probable that we will be unable to meet our obligations as they become due within one year after the date that the financial statements included in this Report are issued.”View the 10-Q filed Aug 12, 2026
Market Cap
$11.80M
Shares
49.88M
Volume · Oct 20
291.16K
Avg daily vol (3M)
7.53M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Chad Oh | Chief Medical Officer | $1,381,767 |
| Alex Wilson | Chief Legal Officer | $1,365,333 |
| Robert Bancroft | President and Chief Executive Officer | $553,855 |
| Marc Forth | Former President and Chief Executive Officer | $135,616 |
| Jost Fischer | Former Interim President and Chief Executive Officer | — |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Marc Forth | Former President and Chief Executive Officer | $5,044,599 |
| Chad Oh | Chief Medical Officer | $2,302,013 |
| Alex Wilson | Chief Legal Officer | $2,143,856 |
| Jost Fischer | Former Interim President and Chief Executive Officer | — |
| Robert Bancroft | President and Chief Executive Officer | — |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Marc Forth | Former President and Chief Executive Officer | $3,982,378 |
| Chad Oh | Chief Medical Officer | $1,649,640 |
| Alex Wilson | Chief Legal Officer | $1,400,077 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Marc Forth | President and Chief Executive Officer | $4,804,637 |
| Chad Oh | Chief Medical Officer | $1,321,831 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Jennifer Sy | Chief Accounting Officer | Appointed | 2026-03-09 |
| John Bencich | Chief Financial Officer | Appointed | 2026-03-09 |
| Robert Bancroft | member of the Board | Appointed | 2025-04-21 |
| Robert Bancroft | Principal Executive Officer, President, Chief Executive Officer | Appointed | 2025-04-21 |
| Jennifer Sy | Chief Accounting Officer and principal financial officer | Appointed | 2025-04-08 |
| Jost Fischer | Interim President, Chief Executive Officer and principal executive officer | Appointed | 2025-04-08 |
| Jost Fischer | Interim Chief Executive Officer | Appointed | 2025-03-27 |
| Marc Forth | President and Chief Executive Officer | Resigned | 2025-03-27 |
| Jennifer Sy | principal accounting officer | Appointed | 2024-05-16 |
| Marc Forth | principal financial officer | Appointed | 2024-05-16 |
| Peter Reynolds | Chief Financial Officer, principal financial officer and principal accounting officer | Terminated | 2024-05-16 |
| Seongsoo Park | Class III director | Appointed | 2024-04-17 |
| Chad Oh | Chief Medical Officer | Appointed | 2023-07-27 |
| Alex Wilson | Executive Vice President, Chief Legal Officer and Corporate Secretary | Appointed | 2023-07-27 |
| Marc Forth | Chief Executive Officer and principal executive officer | Appointed | 2023-07-27 |
| Peter Reynolds | Chief Financial Officer and principal financial officer and principal accounting officer | Appointed | 2023-07-27 |
| Jost Fischer | Chair of the Board | Appointed | 2023-07-27 |
| Shelley Thunen | director | Appointed | 2023-07-27 |
| Robert Palmisano | director | Appointed | 2023-07-27 |
| Eric Carter | director | Appointed | 2023-07-27 |
| Jost Fischer | director | Appointed | 2023-07-27 |
| Marc Forth | director | Appointed | 2023-07-27 |
| Robert Palmisano | Class I, Class II and Class III directors | Appointed | 2023-07-05 |
| Shelley Thunen | Class I, Class II and Class III directors | Appointed | 2023-07-05 |
| Jost Fischer | Class I, Class II and Class III directors | Appointed | 2023-07-05 |
Leadership
- Jost Fischer CEO, Chairman, Board Member
- Marc Forth CEO, CFO, Board Member
- Robert Bancroft CEO, Board Member
- John Bencich CFO
- Peter Reynolds CFO
- Alex Wilson General Counsel
- Jennifer Sy Chief Accounting Officer
- Eric Carter Board Member
- James Lightman Board Member
- Julie B. Andrews Board Member
- Lance A. Berry Board Member
- Robert Palmisano Board Member
- Seongsoo Park Board Member
- Shelley Thunen Board Member